What is GeneDx Holdings's EBITDA margin?

GeneDx Holdings (WGS) reported EBITDA margin of -9% in Q1 2026.

What is the long-term trend for GeneDx Holdings's EBITDA margin?

Over 3 years (2021 to 2025), GeneDx Holdings's EBITDA margin has grown at a -68.1% compound annual growth rate (CAGR), from -87.4% to 2.8%.

What does EBITDA margin mean?

EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.

GeneDx Holdings WGS EBITDA margin

EBITDA margin at other companies

Natera, Inc.NTRA

-11.1%+0.5pp

Quest DiagnosticsDGX

19.4%+0.6pp

RevvityRVTY

26.6%-2.0pp

Labcorp HoldingsLH

15%+1.8pp

IlluminaILMN

25.5%—

Agilent TechnologiesA

25.3%-0.2pp

Other financials

Income statement

See full

Revenue$102.3M+17.4%

Gross profit$68.2M+16.6%

Operating income-$57.5M-1,163%

Net income-$63.3M-870%

EPS (diluted)-$2.16-839%

Balance sheet

See full

Cash & equivalents$94.9M-5.7%

Total debt$96.7M+82.5%

Total equity$254.1M-1.3%

Total assets$506.3M+13.4%

Cash flow

See full

Operating cash flow-$32.4M-418%

CapEx$6.5M+5.3%

Free cash flow-$38.9M-1,059%

Valuation

See full

Market cap$1.72B-24.3%

Enterprise value$1.73B-22.8%

P/S3.9×-3.0×

Profitability

See full

Gross margin69.6%+4.3pp

Operating margin-14.9%—

Net margin-17.6%—

FCF margin3.8%+2.1pp

Returns & leverage

See full

Return on equity-30.4%—

Debt / equity0.4×+0.2×

Current ratio3.1×-0.2×

Where this comes from

Calculated from GeneDx Holdings’s reported figures.

ebitda/total revenue=-9%

Based on trailing twelve months.

The official record: GeneDx Holdings’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about GeneDx Holdings's ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is GeneDx Holdings's EBITDA margin?: GeneDx Holdings (WGS) reported EBITDA margin of -9% in Q1 2026.
What is the long-term trend for GeneDx Holdings's EBITDA margin?: Over 3 years (2021 to 2025), GeneDx Holdings's EBITDA margin has grown at a -68.1% compound annual growth rate (CAGR), from -87.4% to 2.8%.
What does EBITDA margin mean?: EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.